BioCardia, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2011 | FY2010 |
|---|---|---|---|---|---|
| Revenue | $479.0K | $576.0K | $904.0K | $12.0K | $0 |
| Cost of Revenue | $690.0K | $746.0K | $1.1M | $0 | $0 |
| Gross Profit | $-211.0K | $-170.0K | $-157.0K | $12.0K | $0 |
| Gross Margin | -44.1% | -29.5% | -17.4% | 100.0% | — |
| Operating Expenses | |||||
| Research & Development | $5.8M | $3.3M | $1.5M | — | — |
| SG&A Expense | $6.4M | $4.1M | $3.7M | $630.0K | $583.0K |
| Operating Income | $-12.4M | $-7.6M | $-5.4M | $-618.0K | $-583.0K |
| Operating Margin | -2,589.8% | -1,320.8% | -598.3% | -5,150.0% | — |
| Interest Expense | $0 | $1.7M | $1.4M | — | — |
| Pretax Income | — | — | $322.0K | — | — |
| Income Tax Expense | $0 | $0 | $0 | — | — |
| Net Income | $-12.3M | $-10.3M | $-6.7M | $9.7M | $-11.5M |
| Net Margin | -2,569.5% | -1,789.9% | -740.8% | 80,516.7% | — |
| EPS (Basic) | $-1.45 | $-0.62 | $-2.15 | $0.02 | $-0.03 |
| EPS (Diluted) | $-1.45 | $-0.62 | $-2.15 | $0.02 | $-0.03 |
| Shares Outstanding (Basic) | 76.4M | 76.3M | — | — | — |
| Shares Outstanding (Diluted) | 76.4M | 76.3M | 460.6M | 460.6M | 460.6M |
| Dividends Per Share | — | — | — | — | — |